avrg: GSE58827: Dynamics of the Mouse Liver
Gene Symbol | Gene ID | Gene Info |
---|---|---|
Hoxb6
|
ENSMUSG00000000690.4 | homeobox B6 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Hoxb6 | mm10_v2_chr11_+_96292453_96292508 | -0.12 | 4.7e-01 | Click! |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.5 | 1.4 | GO:2000393 | negative regulation of lamellipodium morphogenesis(GO:2000393) |
0.5 | 2.8 | GO:0072592 | oxygen metabolic process(GO:0072592) |
0.2 | 1.0 | GO:1903384 | neuron intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:0036482) positive regulation of mitochondrial electron transport, NADH to ubiquinone(GO:1902958) regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway(GO:1903383) negative regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway(GO:1903384) |
0.2 | 0.7 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
0.2 | 1.9 | GO:0035887 | aortic smooth muscle cell differentiation(GO:0035887) |
0.2 | 0.9 | GO:0090403 | oxidative stress-induced premature senescence(GO:0090403) |
0.2 | 0.5 | GO:2000670 | positive regulation of dendritic cell apoptotic process(GO:2000670) |
0.2 | 0.8 | GO:0015788 | UDP-N-acetylglucosamine transport(GO:0015788) |
0.2 | 2.7 | GO:0048672 | positive regulation of collateral sprouting(GO:0048672) |
0.1 | 0.4 | GO:2001200 | positive regulation of dendritic cell differentiation(GO:2001200) |
0.1 | 1.2 | GO:0006012 | galactose metabolic process(GO:0006012) |
0.1 | 0.3 | GO:0002188 | translation reinitiation(GO:0002188) |
0.1 | 0.2 | GO:0046005 | positive regulation of circadian sleep/wake cycle, REM sleep(GO:0046005) |
0.1 | 0.7 | GO:0061042 | vascular wound healing(GO:0061042) |
0.1 | 0.2 | GO:0010808 | positive regulation of synaptic vesicle priming(GO:0010808) |
0.0 | 0.1 | GO:0010705 | meiotic DNA double-strand break processing involved in reciprocal meiotic recombination(GO:0010705) |
0.0 | 0.8 | GO:0000338 | protein deneddylation(GO:0000338) |
0.0 | 0.2 | GO:0035502 | metanephric part of ureteric bud development(GO:0035502) |
0.0 | 1.4 | GO:0019236 | response to pheromone(GO:0019236) |
0.0 | 0.8 | GO:2000114 | regulation of establishment of cell polarity(GO:2000114) |
0.0 | 0.4 | GO:2001256 | regulation of store-operated calcium entry(GO:2001256) |
0.0 | 0.2 | GO:0060662 | tube lumen cavitation(GO:0060605) salivary gland cavitation(GO:0060662) |
0.0 | 0.9 | GO:0046677 | response to antibiotic(GO:0046677) |
0.0 | 0.5 | GO:2000310 | regulation of N-methyl-D-aspartate selective glutamate receptor activity(GO:2000310) |
0.0 | 0.4 | GO:0001573 | ganglioside metabolic process(GO:0001573) |
0.0 | 0.1 | GO:0015827 | aromatic amino acid transport(GO:0015801) tryptophan transport(GO:0015827) |
0.0 | 2.2 | GO:0007050 | cell cycle arrest(GO:0007050) |
0.0 | 0.2 | GO:1902004 | positive regulation of beta-amyloid formation(GO:1902004) |
0.0 | 0.1 | GO:0035095 | behavioral response to nicotine(GO:0035095) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 1.9 | GO:0071564 | npBAF complex(GO:0071564) |
0.1 | 1.0 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
0.1 | 0.4 | GO:0035032 | phosphatidylinositol 3-kinase complex, class III(GO:0035032) |
0.0 | 0.9 | GO:0033391 | chromatoid body(GO:0033391) |
0.0 | 0.8 | GO:0071437 | invadopodium(GO:0071437) |
0.0 | 0.2 | GO:0098831 | presynaptic active zone cytoplasmic component(GO:0098831) |
0.0 | 0.8 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.0 | 0.8 | GO:1990391 | DNA repair complex(GO:1990391) |
0.0 | 0.1 | GO:0000801 | central element(GO:0000801) |
0.0 | 0.1 | GO:0070847 | core mediator complex(GO:0070847) |
0.0 | 1.4 | GO:0032587 | ruffle membrane(GO:0032587) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 1.2 | GO:0004335 | galactokinase activity(GO:0004335) |
0.3 | 2.8 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
0.2 | 0.7 | GO:0004813 | alanine-tRNA ligase activity(GO:0004813) |
0.2 | 0.7 | GO:0097003 | adipokinetic hormone receptor activity(GO:0097003) |
0.1 | 1.0 | GO:0055131 | C3HC4-type RING finger domain binding(GO:0055131) |
0.1 | 4.6 | GO:0015020 | glucuronosyltransferase activity(GO:0015020) |
0.1 | 0.9 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.1 | 0.5 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
0.1 | 0.4 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
0.0 | 0.4 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
0.0 | 0.8 | GO:0005351 | sugar:proton symporter activity(GO:0005351) |
0.0 | 1.9 | GO:0001105 | RNA polymerase II transcription coactivator activity(GO:0001105) |
0.0 | 0.2 | GO:0005499 | vitamin D binding(GO:0005499) |
0.0 | 4.6 | GO:0008017 | microtubule binding(GO:0008017) |
0.0 | 0.1 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
0.0 | 1.4 | GO:0008013 | beta-catenin binding(GO:0008013) |
0.0 | 1.2 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 2.5 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.0 | 0.9 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.0 | 2.2 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.0 | 1.9 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.0 | 0.5 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.0 | 0.4 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.0 | 0.4 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 2.2 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.1 | 2.8 | REACTOME PHASE1 FUNCTIONALIZATION OF COMPOUNDS | Genes involved in Phase 1 - Functionalization of compounds |
0.0 | 0.9 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.0 | 0.7 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.0 | 0.4 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
0.0 | 2.7 | REACTOME L1CAM INTERACTIONS | Genes involved in L1CAM interactions |
0.0 | 0.2 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
0.0 | 0.5 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
0.0 | 0.8 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |